详细记录  
题名:Cell therapy and the safety of embryonic stem cell-derived grafts
作者:Hannes Hentze, Ralph Graichen and AlanColman
来源:Trends in Biotechnology, Volume 25, Issue 1, January 2007, Pages 24-32
URL :http://dx.doi.org/10.1016/j.tibtech.2006.10.010
日期:070115
摘要:Hannes Hentzea, Ralph Graichena and AlanColmana,

aES Cell International, 11 Biopolis Way, *05–06 Helios Building, 138667 Singapore, Republic of Singapore

Available online 3 November 2006.


Abstract

Recent developments in the identification, in vitro culture and differentiation of stem cells point to the unprecedented potential of these cells, or their derivatives, to cure degenerative disorders. Human embryonic stem cells (hESC) offer the particular advantage of prolonged proliferative capacity and great versatility in the lineages that can be formed in culture. Translating these advantages into clinical benefits faces many challenges, including efficient differentiation into the desired cell type(s), maintaining genetic stability during long-term culture and, finally, ensuring the absence of potentially tumorigenic hESC from the final product. It is this final safety issue that will form the focus of this review.

================  评  论  部  分=================

重要性:
分类:(参照 Faculty of 1000 的分类体系)


评语:

评论密码:   返回前页  [全部]